Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,376 | 141 | 89.4% |
| Education | $333.46 | 19 | 8.8% |
| Debt forgiveness | $67.29 | 4 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ardelyx, Inc. | $572.76 | 5 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $455.73 | 19 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $317.82 | 15 | $0 (2024) |
| Travere Therapeutics, Inc. | $295.86 | 19 | $0 (2024) |
| Amgen Inc. | $294.55 | 11 | $0 (2024) |
| Vifor Pharma, Inc. | $277.95 | 17 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $242.56 | 7 | $0 (2022) |
| AKEBIA THERAPEUTICS INC | $192.67 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $146.01 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $133.69 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,097 | 36 | Ardelyx, Inc. ($559.55) |
| 2023 | $728.06 | 37 | Mallinckrodt Hospital Products Inc. ($174.40) |
| 2022 | $720.09 | 29 | Mallinckrodt Hospital Products Inc. ($159.33) |
| 2021 | $382.08 | 24 | Vifor Pharma, Inc. ($108.09) |
| 2020 | $228.08 | 14 | AKEBIA THERAPEUTICS INC ($71.30) |
| 2019 | $242.75 | 11 | Otsuka America Pharmaceutical, Inc. ($76.91) |
| 2018 | $263.27 | 6 | Mallinckrodt LLC ($112.54) |
| 2017 | $115.12 | 7 | Keryx Biopharmaceuticals, Inc. ($42.68) |
All Payment Transactions
164 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/25/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Catheter Lock Solution | ||||||
| 11/21/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $14.19 | General |
| Category: NEPHROLOGY | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $4.38 | General |
| Category: Cardio-renal | ||||||
| 10/14/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $19.82 | General |
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $5.59 | General |
| Category: Cardio-renal | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $52.11 | General |
| Category: Cardio-renal | ||||||
| 08/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: Cardio-renal | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Nephrology | ||||||
| 08/07/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.12 | General |
| 08/01/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: Cardio-renal | ||||||
| 07/09/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Food and Beverage | In-kind items and services | $485.66 | General |
| Category: NEPHROLOGY | ||||||
| 06/20/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $22.09 | General |
| 06/20/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 06/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/05/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Nephrology | ||||||
| 05/22/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: IMMUNOLOGY | ||||||
| 05/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 05/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Cardio-renal | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 664 | 1,228 | $446,578 | $135,801 |
| 2022 | 11 | 685 | 1,414 | $564,706 | $178,537 |
| 2021 | 15 | 1,019 | 2,059 | $480,680 | $180,921 |
| 2020 | 18 | 1,503 | 2,958 | $577,236 | $221,037 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 31 | 228 | $202,237 | $64,154 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 230 | $74,132 | $20,057 | 27.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 108 | 202 | $58,708 | $18,689 | 31.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 74 | 89 | $39,609 | $11,813 | 29.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 19 | 33 | $24,367 | $7,469 | 30.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 43 | 87 | $15,662 | $4,758 | 30.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 99 | $14,442 | $4,181 | 28.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $15,556 | $3,961 | 25.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 116 | 140 | $1,120 | $435.40 | 38.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 78 | 83 | $747.00 | $283.03 | 37.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 48 | 330 | $299,310 | $94,902 | 31.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 130 | 260 | $67,340 | $21,288 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 191 | $62,648 | $18,328 | 29.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 88 | 98 | $49,098 | $15,009 | 30.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 20 | 43 | $32,293 | $9,890 | 30.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 23 | 139 | $14,317 | $6,411 | 44.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 50 | 93 | $17,112 | $5,429 | 31.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $11,050 | $3,358 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 18 | $8,244 | $2,627 | 31.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 11 | 18 | $1,710 | $676.34 | 39.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 140 | 198 | $1,584 | $619.08 | 39.1% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 39 | 278 | $193,151 | $79,096 | 41.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 167 | 350 | $82,670 | $28,957 | 35.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 106 | 136 | $53,031 | $21,226 | 40.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 100 | 179 | $39,314 | $17,003 | 43.2% |
About Dr. Namrita Baveja, M.D
Dr. Namrita Baveja, M.D is a Nephrology healthcare provider based in Danville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2008. The National Provider Identifier (NPI) number assigned to this provider is 1164678744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Namrita Baveja, M.D has received a total of $3,777 in payments from pharmaceutical and medical device companies, with $1,097 received in 2024. These payments were reported across 164 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,376).
As a Medicare-enrolled provider, Baveja has provided services to 3,871 Medicare beneficiaries, totaling 7,659 services with total Medicare billing of $716,297. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Danville, VA
- Active Since 08/14/2008
- Last Updated 11/09/2010
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1164678744
Products in Payments
- ACTHAR (Biological) $568.27
- XPHOZAH 30 MG (Drug) $485.66
- Veltassa (Drug) $324.21
- Kerendia (Drug) $317.82
- JYNARQUE (Drug) $181.36
- Parsabiv (Biological) $166.78
- BENLYSTA (Biological) $146.01
- Auryxia (Drug) $142.59
- AURYXIA (Drug) $115.42
- IBSRELA (Drug) $87.10
- LOKELMA (Drug) $86.05
- Rayaldee (Drug) $74.85
- Parsabiv (Drug) $62.65
- SAMSCA (Drug) $61.20
- Axonics r-SNM System (Device) $51.81
- RAYALDEE (Drug) $49.88
- LUPKYNIS (Drug) $45.86
- PROVENGE (Drug) $39.43
- Aranesp (Biological) $34.80
- None (Device) $34.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Danville
Dr. Yao-Foli Sekyema, M.d, M.D
Nephrology — Payments: $7,614
Jason George
Nephrology — Payments: $7,175
Dr. Michael Fredericks, M.d, M.D
Nephrology — Payments: $7,101
Dr. Evan Norfolk, M.d, M.D
Nephrology — Payments: $6,548
Dr. Peter Umukoro, M.d, M.D
Nephrology — Payments: $3,678
Dr. Franklin Maddux, Md, MD
Nephrology — Payments: $3,273